Novel polymyxin derivatives are less cytotoxic than polymyxin B to renal proximal tubular cells

Peptides - Tập 35 - Trang 248-252 - 2012
Marie-Paule Mingeot-Leclercq1, Paul M. Tulkens1, Sophie Denamur1, Timo Vaara2, Martti Vaara2,3
1Louvain Drug Research Institute, Pharmacologie Cellulaire et Moléculaire, Université Catholique de Louvain, B-1200 Brussels, Belgium
2Northern Antibiotics Ltd., FI-00720 Helsinki, Finland
3Division of Clinical Microbiology, Helsinki University Hospital, FI-00029 HUSLAB, Helsinki, Finland

Tài liệu tham khảo

Ali, 2009, Pharmacokinetics of novel antimicrobial cationic peptides NAB7061 and NAB739 in rats following intravenous administration, J Antimicrob Chemother, 64, 1067, 10.1093/jac/dkp331

Arias, 2009, Antibiotic-resistant bugs in the 21st century – a clinical super-challenge, New Engl J Med, 360, 439, 10.1056/NEJMp0804651

Boucher, 2009, Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America, Clin Infect Dis, 48, 1, 10.1086/595011

Cantaluppi, 2008, Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors, Intensive Care Med, 34, 1638, 10.1007/s00134-008-1124-6

Denamur, 2008, Apoptosis induced by aminoglycosides in LLC-PK1 cells: comparative study of neomycin, gentamicin, amikacin, and isepamicin using electroporation, Antimicrob Agents Chemother, 52, 2236, 10.1128/AAC.01680-07

Hartzell, 2009, Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center, Clin Infect Dis, 48, 1724, 10.1086/599225

Landman, 2008, Polymyxins revisited, Clin Microbiol Rev, 21, 449, 10.1128/CMR.00006-08

Leventis, 2010, The distribution and function of phosphatidylserine in cellular membranes, Annu Rev Biophys, 39, 407, 10.1146/annurev.biophys.093008.131234

Li, 2003, Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration, Antimicrob Agents Chemother, 47, 1766, 10.1128/AAC.47.5.1766-1770.2003

Livermore, 2009, Has the era of untreatable infections arrived?, J Antimicrob Chemother, 64, i29, 10.1093/jac/dkp255

Ma, 2009, Renal disposition of colistin in the isolated perfused rat kidney, Antimicrob Agents Chemother, 53, 2857, 10.1128/AAC.00030-09

Moestrup, 1995, Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs, J Clin Invest, 96, 1404, 10.1172/JCI118176

Montenez, 1999, Interactions of macrolide antibiotics (erythromycin A, roxithromycin, erythromycylamine [dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models, Toxicol Appl Pharmacol, 156, 129, 10.1006/taap.1999.8632

Nagai, 2004, Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity, Drug Metab Pharmacokin, 19, 159, 10.2133/dmpk.19.159

Nation, 2009, Colistin in the 21st century, Curr Opin Infect Dis, 22, 535, 10.1097/QCO.0b013e328332e672

Pastewski, 2008, Parenteral polymyxin B use in patients with multidrug-resistant Gram-negative bacteremia and urinary tract infections: a retrospective case series, Ann Pharmacother, 42, 1177, 10.1345/aph.1K346

Servais, 2006, Gentamicin causes apoptosis at low concentrations in renal LLC-PK1 cells subjected to electroporation, Antimicrob Agents Chemother, 50, 1213, 10.1128/AAC.50.4.1213-1221.2006

Servais, 2005, Gentamicin-induced apoptosis in LLC-PK1 cells: involvement of lysosomes and mitochondria, Toxicol Appl Pharmacol, 206, 321, 10.1016/j.taap.2004.11.024

Shino, 2003, Role of poly(ADP-ribose)polymerase in cisplatin-induced injury in LLC-PK1 cells, Free Radical Biol Med, 35, 966, 10.1016/S0891-5849(03)00470-2

Vaara, 1992, Agents that increase the permeability of the outer membrane, Microbiol Rev, 56, 395, 10.1128/MMBR.56.3.395-411.1992

Vaara, 2009, New approaches in peptide antibiotics, Curr Opin Pharmacol, 9, 571, 10.1016/j.coph.2009.08.002

Vaara, 2010, Polymyxins and their novel derivatives, Curr Opin Microbiol, 13, 574, 10.1016/j.mib.2010.09.002

Vaara, 2008, Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents, Antimicrob Agents Chemother, 52, 3229, 10.1128/AAC.00405-08

Vaara, 2010, A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane, Antimicrob Agents Chemother, 54, 3341, 10.1128/AAC.01439-09

Vaara, 2010, Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampin and clarithromycin, J Antimicrob Chemother, 65, 942, 10.1093/jac/dkq040

Vassault, 1983, Lactate dehydrogenase, 118

Yano, 2003, Cyclic AMP reverses radiocontrast media-induced apoptosis in LLC-PK1 cells by activating A kinase/PI3 kinase, Kidney Int, 64, 2052, 10.1046/j.1523-1755.2003.00335.x

Zavascki, 2008, Pharmacokinetics of intravenous polymyxin B in critically ill patients, Clin Infect Dis, 47, 1298, 10.1086/592577